nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNA6—skin of body—systemic scleroderma	0.00699	0.0969	CbGeAlD
Galantamine—CHRNG—tendon—systemic scleroderma	0.00502	0.0695	CbGeAlD
Galantamine—CHRNB4—tendon—systemic scleroderma	0.00483	0.067	CbGeAlD
Galantamine—CHRNG—lung—systemic scleroderma	0.0044	0.061	CbGeAlD
Galantamine—CHRNA10—tendon—systemic scleroderma	0.00426	0.059	CbGeAlD
Galantamine—CHRNB2—smooth muscle tissue—systemic scleroderma	0.00407	0.0564	CbGeAlD
Galantamine—CHRND—tendon—systemic scleroderma	0.00398	0.0551	CbGeAlD
Galantamine—CHRNA3—skin of body—systemic scleroderma	0.0039	0.054	CbGeAlD
Galantamine—CHRND—lung—systemic scleroderma	0.00349	0.0484	CbGeAlD
Galantamine—CHRNA1—tendon—systemic scleroderma	0.00332	0.046	CbGeAlD
Galantamine—CHRNB2—tendon—systemic scleroderma	0.00306	0.0424	CbGeAlD
Galantamine—CHRNB2—lung—systemic scleroderma	0.00268	0.0372	CbGeAlD
Galantamine—CHRNA3—lung—systemic scleroderma	0.0026	0.0361	CbGeAlD
Galantamine—CHRNB1—tendon—systemic scleroderma	0.00256	0.0355	CbGeAlD
Galantamine—CHRNA7—skin of body—systemic scleroderma	0.00254	0.0353	CbGeAlD
Galantamine—ACHE—tendon—systemic scleroderma	0.00222	0.0308	CbGeAlD
Galantamine—CHRNA7—digestive system—systemic scleroderma	0.00204	0.0282	CbGeAlD
Galantamine—CHRNA4—digestive system—systemic scleroderma	0.00201	0.0278	CbGeAlD
Galantamine—CHRNA4—lung—systemic scleroderma	0.00168	0.0232	CbGeAlD
Galantamine—BCHE—smooth muscle tissue—systemic scleroderma	0.00145	0.0202	CbGeAlD
Galantamine—BCHE—skin of body—systemic scleroderma	0.00144	0.0199	CbGeAlD
Galantamine—BCHE—digestive system—systemic scleroderma	0.00115	0.0159	CbGeAlD
Galantamine—BCHE—lung—systemic scleroderma	0.000959	0.0133	CbGeAlD
Galantamine—Fatigue—Leflunomide—systemic scleroderma	0.000817	0.00088	CcSEcCtD
Galantamine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000811	0.000874	CcSEcCtD
Galantamine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000811	0.000874	CcSEcCtD
Galantamine—Constipation—Leflunomide—systemic scleroderma	0.00081	0.000873	CcSEcCtD
Galantamine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000808	0.00087	CcSEcCtD
Galantamine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000803	0.000866	CcSEcCtD
Galantamine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000865	CcSEcCtD
Galantamine—Shock—Lisinopril—systemic scleroderma	0.000801	0.000863	CcSEcCtD
Galantamine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000797	0.000859	CcSEcCtD
Galantamine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000795	0.000857	CcSEcCtD
Galantamine—Tachycardia—Lisinopril—systemic scleroderma	0.000794	0.000856	CcSEcCtD
Galantamine—Abdominal pain—Azathioprine—systemic scleroderma	0.000793	0.000855	CcSEcCtD
Galantamine—Body temperature increased—Azathioprine—systemic scleroderma	0.000793	0.000855	CcSEcCtD
Galantamine—Skin disorder—Lisinopril—systemic scleroderma	0.000791	0.000852	CcSEcCtD
Galantamine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000788	0.000849	CcSEcCtD
Galantamine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000787	0.000848	CcSEcCtD
Galantamine—Diarrhoea—Captopril—systemic scleroderma	0.000786	0.000847	CcSEcCtD
Galantamine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000785	0.000847	CcSEcCtD
Galantamine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000785	0.000846	CcSEcCtD
Galantamine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000784	0.000844	CcSEcCtD
Galantamine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000781	0.000841	CcSEcCtD
Galantamine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00078	0.000841	CcSEcCtD
Galantamine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000779	0.00084	CcSEcCtD
Galantamine—Nausea—Mometasone—systemic scleroderma	0.000777	0.000838	CcSEcCtD
Galantamine—Anorexia—Lisinopril—systemic scleroderma	0.000776	0.000836	CcSEcCtD
Galantamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000775	0.000835	CcSEcCtD
Galantamine—CYP3A4—digestive system—systemic scleroderma	0.000773	0.0107	CbGeAlD
Galantamine—Ataxia—Methotrexate—systemic scleroderma	0.000773	0.000833	CcSEcCtD
Galantamine—Constipation—Mycophenolic acid—systemic scleroderma	0.000773	0.000833	CcSEcCtD
Galantamine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000772	0.000832	CcSEcCtD
Galantamine—Weight decreased—Prednisone—systemic scleroderma	0.000769	0.000829	CcSEcCtD
Galantamine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000828	CcSEcCtD
Galantamine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000767	0.000826	CcSEcCtD
Galantamine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000762	0.000822	CcSEcCtD
Galantamine—CYP2D6—digestive system—systemic scleroderma	0.000761	0.0105	CbGeAlD
Galantamine—Hypotension—Lisinopril—systemic scleroderma	0.00076	0.00082	CcSEcCtD
Galantamine—Dizziness—Captopril—systemic scleroderma	0.00076	0.000819	CcSEcCtD
Galantamine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000816	CcSEcCtD
Galantamine—Depression—Prednisone—systemic scleroderma	0.000756	0.000814	CcSEcCtD
Galantamine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000754	0.000813	CcSEcCtD
Galantamine—Abdominal pain—Leflunomide—systemic scleroderma	0.000749	0.000807	CcSEcCtD
Galantamine—Body temperature increased—Leflunomide—systemic scleroderma	0.000749	0.000807	CcSEcCtD
Galantamine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000745	0.000803	CcSEcCtD
Galantamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000802	CcSEcCtD
Galantamine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000802	CcSEcCtD
Galantamine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000802	CcSEcCtD
Galantamine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000743	0.000801	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000741	0.000799	CcSEcCtD
Galantamine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000799	CcSEcCtD
Galantamine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000739	0.000796	CcSEcCtD
Galantamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000739	0.000796	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000739	0.000796	CcSEcCtD
Galantamine—Insomnia—Lisinopril—systemic scleroderma	0.000736	0.000793	CcSEcCtD
Galantamine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000735	0.000792	CcSEcCtD
Galantamine—Paraesthesia—Lisinopril—systemic scleroderma	0.000731	0.000788	CcSEcCtD
Galantamine—Vomiting—Captopril—systemic scleroderma	0.000731	0.000788	CcSEcCtD
Galantamine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000784	CcSEcCtD
Galantamine—Rash—Captopril—systemic scleroderma	0.000725	0.000781	CcSEcCtD
Galantamine—Dermatitis—Captopril—systemic scleroderma	0.000724	0.00078	CcSEcCtD
Galantamine—Somnolence—Lisinopril—systemic scleroderma	0.000724	0.00078	CcSEcCtD
Galantamine—Headache—Captopril—systemic scleroderma	0.00072	0.000776	CcSEcCtD
Galantamine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000719	0.000775	CcSEcCtD
Galantamine—Dyspepsia—Lisinopril—systemic scleroderma	0.000716	0.000772	CcSEcCtD
Galantamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000714	0.00077	CcSEcCtD
Galantamine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000714	0.00077	CcSEcCtD
Galantamine—Decreased appetite—Lisinopril—systemic scleroderma	0.000707	0.000763	CcSEcCtD
Galantamine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000703	0.000757	CcSEcCtD
Galantamine—Fatigue—Lisinopril—systemic scleroderma	0.000702	0.000756	CcSEcCtD
Galantamine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000702	0.000756	CcSEcCtD
Galantamine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000754	CcSEcCtD
Galantamine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000752	CcSEcCtD
Galantamine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000698	0.000752	CcSEcCtD
Galantamine—Constipation—Lisinopril—systemic scleroderma	0.000696	0.00075	CcSEcCtD
Galantamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000696	0.00075	CcSEcCtD
Galantamine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000747	CcSEcCtD
Galantamine—Bradycardia—Prednisone—systemic scleroderma	0.000693	0.000746	CcSEcCtD
Galantamine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000743	CcSEcCtD
Galantamine—Diarrhoea—Azathioprine—systemic scleroderma	0.000686	0.00074	CcSEcCtD
Galantamine—Haemoglobin—Prednisone—systemic scleroderma	0.000684	0.000737	CcSEcCtD
Galantamine—Nausea—Captopril—systemic scleroderma	0.000683	0.000736	CcSEcCtD
Galantamine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000681	0.000734	CcSEcCtD
Galantamine—Haemorrhage—Prednisone—systemic scleroderma	0.00068	0.000733	CcSEcCtD
Galantamine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00068	0.000733	CcSEcCtD
Galantamine—Asthenia—Leflunomide—systemic scleroderma	0.00068	0.000732	CcSEcCtD
Galantamine—Hallucination—Prednisone—systemic scleroderma	0.000677	0.00073	CcSEcCtD
Galantamine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000671	0.000723	CcSEcCtD
Galantamine—Connective tissue disorder—Prednisone—systemic scleroderma	0.000669	0.000721	CcSEcCtD
Galantamine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000666	0.000718	CcSEcCtD
Galantamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000666	0.000717	CcSEcCtD
Galantamine—Dizziness—Azathioprine—systemic scleroderma	0.000663	0.000715	CcSEcCtD
Galantamine—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00066	0.000712	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00065	0.0007	CcSEcCtD
Galantamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000648	0.000699	CcSEcCtD
Galantamine—Diarrhoea—Leflunomide—systemic scleroderma	0.000648	0.000698	CcSEcCtD
Galantamine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000645	0.000695	CcSEcCtD
Galantamine—Abdominal pain—Lisinopril—systemic scleroderma	0.000643	0.000693	CcSEcCtD
Galantamine—Body temperature increased—Lisinopril—systemic scleroderma	0.000643	0.000693	CcSEcCtD
Galantamine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00069	CcSEcCtD
Galantamine—Vomiting—Azathioprine—systemic scleroderma	0.000638	0.000687	CcSEcCtD
Galantamine—Pneumonia—Methotrexate—systemic scleroderma	0.000637	0.000687	CcSEcCtD
Galantamine—Eye disorder—Prednisone—systemic scleroderma	0.000636	0.000685	CcSEcCtD
Galantamine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000634	0.000683	CcSEcCtD
Galantamine—Rash—Azathioprine—systemic scleroderma	0.000632	0.000682	CcSEcCtD
Galantamine—Dermatitis—Azathioprine—systemic scleroderma	0.000632	0.000681	CcSEcCtD
Galantamine—Depression—Methotrexate—systemic scleroderma	0.000632	0.000681	CcSEcCtD
Galantamine—Flushing—Prednisone—systemic scleroderma	0.000631	0.000681	CcSEcCtD
Galantamine—Headache—Azathioprine—systemic scleroderma	0.000628	0.000677	CcSEcCtD
Galantamine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000628	0.000677	CcSEcCtD
Galantamine—Dizziness—Leflunomide—systemic scleroderma	0.000626	0.000675	CcSEcCtD
Galantamine—Renal failure—Methotrexate—systemic scleroderma	0.000623	0.000671	CcSEcCtD
Galantamine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00062	0.000668	CcSEcCtD
Galantamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000618	0.000666	CcSEcCtD
Galantamine—Angiopathy—Prednisone—systemic scleroderma	0.000617	0.000665	CcSEcCtD
Galantamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000616	0.000664	CcSEcCtD
Galantamine—Immune system disorder—Prednisone—systemic scleroderma	0.000615	0.000662	CcSEcCtD
Galantamine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000657	CcSEcCtD
Galantamine—Arrhythmia—Prednisone—systemic scleroderma	0.000608	0.000655	CcSEcCtD
Galantamine—Haematuria—Methotrexate—systemic scleroderma	0.000604	0.000651	CcSEcCtD
Galantamine—Vomiting—Leflunomide—systemic scleroderma	0.000602	0.000649	CcSEcCtD
Galantamine—Hypersensitivity—Lisinopril—systemic scleroderma	0.0006	0.000646	CcSEcCtD
Galantamine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000599	0.000646	CcSEcCtD
Galantamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000598	0.000644	CcSEcCtD
Galantamine—Epistaxis—Methotrexate—systemic scleroderma	0.000597	0.000644	CcSEcCtD
Galantamine—Rash—Leflunomide—systemic scleroderma	0.000597	0.000644	CcSEcCtD
Galantamine—Dermatitis—Leflunomide—systemic scleroderma	0.000597	0.000643	CcSEcCtD
Galantamine—Mental disorder—Prednisone—systemic scleroderma	0.000596	0.000642	CcSEcCtD
Galantamine—Nausea—Azathioprine—systemic scleroderma	0.000596	0.000642	CcSEcCtD
Galantamine—Headache—Leflunomide—systemic scleroderma	0.000593	0.00064	CcSEcCtD
Galantamine—Malnutrition—Prednisone—systemic scleroderma	0.000592	0.000638	CcSEcCtD
Galantamine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000633	CcSEcCtD
Galantamine—Asthenia—Lisinopril—systemic scleroderma	0.000584	0.000629	CcSEcCtD
Galantamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000628	CcSEcCtD
Galantamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000575	0.000619	CcSEcCtD
Galantamine—Haemoglobin—Methotrexate—systemic scleroderma	0.000571	0.000616	CcSEcCtD
Galantamine—Rash—Mycophenolic acid—systemic scleroderma	0.00057	0.000614	CcSEcCtD
Galantamine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000569	0.000613	CcSEcCtD
Galantamine—Haemorrhage—Methotrexate—systemic scleroderma	0.000569	0.000613	CcSEcCtD
Galantamine—Hepatitis—Methotrexate—systemic scleroderma	0.000569	0.000613	CcSEcCtD
Galantamine—Headache—Mycophenolic acid—systemic scleroderma	0.000566	0.00061	CcSEcCtD
Galantamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000608	CcSEcCtD
Galantamine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000608	CcSEcCtD
Galantamine—Nausea—Leflunomide—systemic scleroderma	0.000563	0.000606	CcSEcCtD
Galantamine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000562	0.000605	CcSEcCtD
Galantamine—Vision blurred—Prednisone—systemic scleroderma	0.000558	0.000602	CcSEcCtD
Galantamine—Urethral disorder—Methotrexate—systemic scleroderma	0.000557	0.000601	CcSEcCtD
Galantamine—Diarrhoea—Lisinopril—systemic scleroderma	0.000557	0.0006	CcSEcCtD
Galantamine—Ill-defined disorder—Prednisone—systemic scleroderma	0.00055	0.000592	CcSEcCtD
Galantamine—Visual impairment—Methotrexate—systemic scleroderma	0.000548	0.000591	CcSEcCtD
Galantamine—Anaemia—Prednisone—systemic scleroderma	0.000547	0.00059	CcSEcCtD
Galantamine—Agitation—Prednisone—systemic scleroderma	0.000544	0.000587	CcSEcCtD
Galantamine—Dizziness—Lisinopril—systemic scleroderma	0.000538	0.00058	CcSEcCtD
Galantamine—Nausea—Mycophenolic acid—systemic scleroderma	0.000537	0.000578	CcSEcCtD
Galantamine—Malaise—Prednisone—systemic scleroderma	0.000534	0.000576	CcSEcCtD
Galantamine—Vertigo—Prednisone—systemic scleroderma	0.000532	0.000574	CcSEcCtD
Galantamine—Eye disorder—Methotrexate—systemic scleroderma	0.000531	0.000573	CcSEcCtD
Galantamine—Syncope—Prednisone—systemic scleroderma	0.000531	0.000572	CcSEcCtD
Galantamine—Tinnitus—Methotrexate—systemic scleroderma	0.00053	0.000571	CcSEcCtD
Galantamine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000528	0.000569	CcSEcCtD
Galantamine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000525	0.000566	CcSEcCtD
Galantamine—Loss of consciousness—Prednisone—systemic scleroderma	0.000521	0.000561	CcSEcCtD
Galantamine—Vomiting—Lisinopril—systemic scleroderma	0.000517	0.000558	CcSEcCtD
Galantamine—Angiopathy—Methotrexate—systemic scleroderma	0.000516	0.000556	CcSEcCtD
Galantamine—Immune system disorder—Methotrexate—systemic scleroderma	0.000514	0.000554	CcSEcCtD
Galantamine—Rash—Lisinopril—systemic scleroderma	0.000513	0.000553	CcSEcCtD
Galantamine—Convulsion—Prednisone—systemic scleroderma	0.000513	0.000553	CcSEcCtD
Galantamine—Dermatitis—Lisinopril—systemic scleroderma	0.000513	0.000553	CcSEcCtD
Galantamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000512	0.000551	CcSEcCtD
Galantamine—Hypertension—Prednisone—systemic scleroderma	0.000511	0.000551	CcSEcCtD
Galantamine—Headache—Lisinopril—systemic scleroderma	0.00051	0.00055	CcSEcCtD
Galantamine—Arthralgia—Prednisone—systemic scleroderma	0.000504	0.000543	CcSEcCtD
Galantamine—Myalgia—Prednisone—systemic scleroderma	0.000504	0.000543	CcSEcCtD
Galantamine—Anxiety—Prednisone—systemic scleroderma	0.000502	0.000542	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000501	0.00054	CcSEcCtD
Galantamine—Discomfort—Prednisone—systemic scleroderma	0.000498	0.000537	CcSEcCtD
Galantamine—Mental disorder—Methotrexate—systemic scleroderma	0.000498	0.000537	CcSEcCtD
Galantamine—Malnutrition—Methotrexate—systemic scleroderma	0.000495	0.000533	CcSEcCtD
Galantamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000526	CcSEcCtD
Galantamine—Dysgeusia—Methotrexate—systemic scleroderma	0.000485	0.000522	CcSEcCtD
Galantamine—Nausea—Lisinopril—systemic scleroderma	0.000483	0.000521	CcSEcCtD
Galantamine—Back pain—Methotrexate—systemic scleroderma	0.000479	0.000516	CcSEcCtD
Galantamine—Shock—Prednisone—systemic scleroderma	0.000476	0.000513	CcSEcCtD
Galantamine—Nervous system disorder—Prednisone—systemic scleroderma	0.000474	0.000511	CcSEcCtD
Galantamine—Tachycardia—Prednisone—systemic scleroderma	0.000472	0.000508	CcSEcCtD
Galantamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000508	CcSEcCtD
Galantamine—Skin disorder—Prednisone—systemic scleroderma	0.00047	0.000506	CcSEcCtD
Galantamine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000467	0.000504	CcSEcCtD
Galantamine—Vision blurred—Methotrexate—systemic scleroderma	0.000466	0.000503	CcSEcCtD
Galantamine—Anorexia—Prednisone—systemic scleroderma	0.000461	0.000497	CcSEcCtD
Galantamine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000459	0.000495	CcSEcCtD
Galantamine—Anaemia—Methotrexate—systemic scleroderma	0.000457	0.000493	CcSEcCtD
Galantamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000453	0.000489	CcSEcCtD
Galantamine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00045	0.000485	CcSEcCtD
Galantamine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000449	0.000484	CcSEcCtD
Galantamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000447	0.000481	CcSEcCtD
Galantamine—Malaise—Methotrexate—systemic scleroderma	0.000446	0.000481	CcSEcCtD
Galantamine—Vertigo—Methotrexate—systemic scleroderma	0.000445	0.000479	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00044	0.000475	CcSEcCtD
Galantamine—Insomnia—Prednisone—systemic scleroderma	0.000437	0.000471	CcSEcCtD
Galantamine—Paraesthesia—Prednisone—systemic scleroderma	0.000434	0.000468	CcSEcCtD
Galantamine—Cough—Methotrexate—systemic scleroderma	0.000432	0.000466	CcSEcCtD
Galantamine—Convulsion—Methotrexate—systemic scleroderma	0.000429	0.000462	CcSEcCtD
Galantamine—Dyspepsia—Prednisone—systemic scleroderma	0.000425	0.000459	CcSEcCtD
Galantamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000424	0.000457	CcSEcCtD
Galantamine—Chest pain—Methotrexate—systemic scleroderma	0.000421	0.000454	CcSEcCtD
Galantamine—Myalgia—Methotrexate—systemic scleroderma	0.000421	0.000454	CcSEcCtD
Galantamine—Arthralgia—Methotrexate—systemic scleroderma	0.000421	0.000454	CcSEcCtD
Galantamine—Decreased appetite—Prednisone—systemic scleroderma	0.00042	0.000453	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000418	0.000451	CcSEcCtD
Galantamine—Fatigue—Prednisone—systemic scleroderma	0.000417	0.000449	CcSEcCtD
Galantamine—Discomfort—Methotrexate—systemic scleroderma	0.000416	0.000449	CcSEcCtD
Galantamine—Constipation—Prednisone—systemic scleroderma	0.000413	0.000445	CcSEcCtD
Galantamine—Confusional state—Methotrexate—systemic scleroderma	0.000407	0.000439	CcSEcCtD
Galantamine—Feeling abnormal—Prednisone—systemic scleroderma	0.000398	0.000429	CcSEcCtD
Galantamine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000396	0.000427	CcSEcCtD
Galantamine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000396	0.000426	CcSEcCtD
Galantamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000395	0.000426	CcSEcCtD
Galantamine—Skin disorder—Methotrexate—systemic scleroderma	0.000392	0.000423	CcSEcCtD
Galantamine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000391	0.000421	CcSEcCtD
Galantamine—Anorexia—Methotrexate—systemic scleroderma	0.000385	0.000415	CcSEcCtD
Galantamine—Abdominal pain—Prednisone—systemic scleroderma	0.000382	0.000412	CcSEcCtD
Galantamine—Body temperature increased—Prednisone—systemic scleroderma	0.000382	0.000412	CcSEcCtD
Galantamine—Hypotension—Methotrexate—systemic scleroderma	0.000377	0.000407	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000368	0.000397	CcSEcCtD
Galantamine—Insomnia—Methotrexate—systemic scleroderma	0.000365	0.000394	CcSEcCtD
Galantamine—Paraesthesia—Methotrexate—systemic scleroderma	0.000363	0.000391	CcSEcCtD
Galantamine—Somnolence—Methotrexate—systemic scleroderma	0.000359	0.000387	CcSEcCtD
Galantamine—Hypersensitivity—Prednisone—systemic scleroderma	0.000356	0.000384	CcSEcCtD
Galantamine—Dyspepsia—Methotrexate—systemic scleroderma	0.000356	0.000383	CcSEcCtD
Galantamine—Decreased appetite—Methotrexate—systemic scleroderma	0.000351	0.000378	CcSEcCtD
Galantamine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000349	0.000376	CcSEcCtD
Galantamine—Fatigue—Methotrexate—systemic scleroderma	0.000348	0.000375	CcSEcCtD
Galantamine—Asthenia—Prednisone—systemic scleroderma	0.000347	0.000374	CcSEcCtD
Galantamine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000333	0.000359	CcSEcCtD
Galantamine—Diarrhoea—Prednisone—systemic scleroderma	0.000331	0.000356	CcSEcCtD
Galantamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00033	0.000356	CcSEcCtD
Galantamine—Dizziness—Prednisone—systemic scleroderma	0.00032	0.000345	CcSEcCtD
Galantamine—Abdominal pain—Methotrexate—systemic scleroderma	0.000319	0.000344	CcSEcCtD
Galantamine—Body temperature increased—Methotrexate—systemic scleroderma	0.000319	0.000344	CcSEcCtD
Galantamine—Vomiting—Prednisone—systemic scleroderma	0.000307	0.000331	CcSEcCtD
Galantamine—Rash—Prednisone—systemic scleroderma	0.000305	0.000328	CcSEcCtD
Galantamine—Dermatitis—Prednisone—systemic scleroderma	0.000304	0.000328	CcSEcCtD
Galantamine—Headache—Prednisone—systemic scleroderma	0.000303	0.000326	CcSEcCtD
Galantamine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000298	0.000321	CcSEcCtD
Galantamine—Asthenia—Methotrexate—systemic scleroderma	0.00029	0.000312	CcSEcCtD
Galantamine—Nausea—Prednisone—systemic scleroderma	0.000287	0.000309	CcSEcCtD
Galantamine—Diarrhoea—Methotrexate—systemic scleroderma	0.000276	0.000298	CcSEcCtD
Galantamine—Dizziness—Methotrexate—systemic scleroderma	0.000267	0.000288	CcSEcCtD
Galantamine—Vomiting—Methotrexate—systemic scleroderma	0.000257	0.000277	CcSEcCtD
Galantamine—Rash—Methotrexate—systemic scleroderma	0.000255	0.000275	CcSEcCtD
Galantamine—Dermatitis—Methotrexate—systemic scleroderma	0.000254	0.000274	CcSEcCtD
Galantamine—Headache—Methotrexate—systemic scleroderma	0.000253	0.000273	CcSEcCtD
Galantamine—Nausea—Methotrexate—systemic scleroderma	0.00024	0.000259	CcSEcCtD
